Usefulness of magnetic resonance imaging in prostate cancer;Utilidad de la resonancia magnética en el cáncer de próstata

Radiologia

Volumn 52, Issue 6, 2010, Pages 513-524

  Vilanova, J C ^a,b,c   Comet, J ^d   Garcia Figueiras, R ^e   Barcelo J ^a,b,c   Boada, M ^a  

^a Clnica Girona   (Spain)

^b Hospital Sta   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d Hospital Universitario Dr J Trueta   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Contrast agent; Diffusion MRI; Magnetic resonance imaging; Prostate tumors; Spectroscopy

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; SPECTROSCOPY; TREATMENT RESPONSE;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 78650169969     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/j.rx.2010.06.003     Document Type: Article

References (69)

1. J. Borras, R. Marcos-Gragera, A. Torres, and J.A. Espinas Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 19852019: prostate cancer Med Clin (Barc) 131 Suppl 1 2008 63 66
2. A.W. Roddam, M.J. Duffy, F.C. Hamdy, A.M. Ward, J. Patnick, and C.P. Price Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 210 ng/ml: systematic review and meta-analysis Eur Urol 48 2005 386 399 (Pubitemid 41188392)
3. G.L. Andriole, and W.J. Catalona Using PSA to screen for prostate cancer. The Washington University experience Urol Clin North Am 20 1993 647 651 (Pubitemid 24141157)
4. J.B. Shah, A.C. Reese, J.M. McKiernan, and M.C. Benson PSA updated: still relevant in the new millennium? Eur Urol 47 2005 427 432 (Pubitemid 40357882)
5. C.G. Arcangeli, D.K. Ornstein, D.W. Keetch, and G.L. Andriole Prostate-specific antigen as a screening test for prostate cancer. The United States experience Urol Clin North Am 24 1997 299 306 (Pubitemid 27169254)
6. C.E. Engeler, N.F. Wasserman, and G. Zhang Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives Urology 40 1992 346 350
7. B. Turkbey, P.S. Albert, K. Kurdziel, and P.L. Choyke Imaging localized prostate cancer: current approaches and new developments Am J Roentgenol 192 2009 1471 1480
8. H. Hricak, P.L. Choyke, S.C. Eberhardt, S.A. Leibel, and P.T. Scardino Imaging prostate cancer: a multidisciplinary perspective Radiology 243 2007 28 53 (Pubitemid 46579693)
9. Y.J. Choi, J.K. Kim, N. Kim, K.W. Kim, E.K. Choi, and K.S. Cho Functional MR imaging of prostate cancer Radiographics 27 2007 63 75
10. A. Shukla-Dave, H. Hricak, M.W. Kattan, D. Pucar, K. Kuroiwa, and H.N. Chen The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis BJU Int 99 2007 786 793 (Pubitemid 46439567)
11. Y. Mazaheri, A. Shukla-Dave, A. Muellner, and H. Hricak MR imaging of the prostate in clinical practice MAGMA 21 2008 379 392
12. D. Beyersdorff, K. Taymoorian, T. Knosel, D. Schnorr, R. Felix, and B. Hamm MRI of Prostate Cancer at 1.5 and 3.0 T: Comparison of Image Quality in Tumor Detection and Staging Am J Roentgenol 185 2005 1214 1220
13. A. Qayyum, F.V. Coakley, Y. Lu, J.D. Olpin, L. Wu, and B.M. Yeh Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging Am J Roentgenol 183 2004 1079 1083 (Pubitemid 44185100)
14. T. Tamada, T. Sone, Y. Jo, A. Yamamoto, T. Yamashita, and N. Egashira Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis Radiology 248 2008 531 539
15. K. Tsuda, K.K. Yu, F.V. Coakley, S.K. Srivastav, J.E. Scheidler, and H. Hricak Detection of extracapsular extension of prostate cancer: role of fat suppression endorectal MRI J Comput Assist Tomogr 23 1999 74 78 (Pubitemid 29095472)
16. J.E. McNeal The zonal anatomy of the prostate Prostate 2 1981 35 49 (Pubitemid 11030893)
17. J.C. Vilanova, and J. Barcelo Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging Abdom Imaging 32 2007 253 261 (Pubitemid 46883672)
18. J. Kurhanewicz, and D.B. Vigneron Advances in MR spectroscopy of the prostate Magn Reson Imaging Clin N Am 16 2008 697-x
19. 3) spatial resolution Radiology 198 1996 795 805 (Pubitemid 26066301)
20. O. Akin, E. Sala, C.S. Moskowitz, K. Kuroiwa, N.M. Ishill, and D. Pucar Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging Radiology 239 2006 784 792 (Pubitemid 43830614)
21. K.L. Zakian, S. Eberhardt, H. Hricak, A. Shukla-Dave, S. Kleinman, and M. Muruganandham Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging - initial results Radiology 229 2003 241 247 (Pubitemid 37152131)
22. D.M. Somford, J.J. Futterer, T. Hambrock, and J.O. Barentsz Diffusion and perfusion MR imaging of the prostate Magn Reson Imaging Clin N Am 16 2008 685 695 ix
23. A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoeny, and T. Takahara Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125 (Pubitemid 41628023)
24. P. Gibbs, D.J. Tozer, G.P. Liney, and L.W. Turnbull Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate Magn Reson Med 46 2001 1054 1058 (Pubitemid 33104291)
25. R. Alonzi, A.R. Padhani, and C. Allen Dynamic contrast enhanced MRI in prostate cancer Eur J Radiol 63 2007 335 350 (Pubitemid 47321040)
26. I. Ocak, M. Bernardo, G. Metzger, T. Barrett, P. Pinto, and P.S. Albert Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters Am J Roentgenol 189 2007 849
27. F.A. Van Dorsten, G.M. van der, M.R. Engelbrecht, G.J. van Leenders, A. Verhofstad, and M. Rijpkema Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer J Magn Reson Imaging 20 2004 279 287 (Pubitemid 38970937)
28. M.R. Engelbrecht, H.J. Huisman, R.J. Laheij, G.J. Jager, G.J. van Leenders, and C.A. Hulsbergen-Van De Kaa Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging Radiology 229 2003 248 254 (Pubitemid 37152132)
29. J.C. Vilanova, and J. Barcelo Diffusion-weighted whole-body MR screening Eur J Radiol 67 2008 440 447
30. H.U. Ahmed, A. Kirkham, M. Arya, R. Illing, A. Freeman, and C. Allen Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6 2009 197 206
31. D. Amsellem-Ouazana, P. Younes, S. Conquy, M. Peyromaure, T. Flam, and B. Debre Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study Eur Urol 47 2005 582 586 (Pubitemid 40521900)
32. J. Comet-Batlle, J.C. Vilanova-Busquets, J.M. Saladie-Roig, A. Gelabert-Mas, and C. Barcelo-Vidal The value of endorectal MRI in the early diagnosis of prostate cancer Eur Urol 44 2003 201 207 (Pubitemid 36917004)
33. J.C. Vilanova, J. Comet, A. Capdevila, J. Barcelo, J.L. Dolz, and M. Huguet The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients Eur Radiol 11 2001 229 235 (Pubitemid 32755441)
34. J.J. Futterer, S.W. Heijmink, T.W. Scheenen, J. Veltman, H.J. Huisman, and P. Vos Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2006 449 458 (Pubitemid 44632891)
35. S.A. Reinsberg, G.S. Payne, S.F. Riches, S. Ashley, J.M. Brewster, and V.A. Morgan Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection Am J Roentgenol 188 2007 91 98 (Pubitemid 46012494)
36. A. Tanimoto, J. Nakashima, H. Kohno, H. Shinmoto, and S. Kuribayashi Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging J Magn Reson Imaging 25 2007 146 152 (Pubitemid 46095209)
37. J.C. Vilanova, J. Comet, C. Barcelo-Vidal, J. Barcelo, E. Lpez-Bonet, and A. Maroto Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy Radiology 253 2009 135 143
38. Y. Mazaheri, A. Shukla-Dave, H. Hricak, S.W. Fine, J. Zhang, and G. Inurrigarro Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings Radiology 246 2008 480 488
39. M.A. Haider, T.H. van der Kwast, J. Tanguay, A.J. Evans, A.T. Hashmi, and G. Lockwood Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer Am J Roentgenol 189 2007 323 328 (Pubitemid 47195916)
40. H.K. Lim, J.K. Kim, K.A. Kim, and K.S. Cho Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection - a multireader study Radiology 250 2009 145 151
41. H. Li, K. Sugimura, Y. Kaji, Y. Kitamura, M. Fujii, and I. Hara Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone Am J Roentgenol 186 2006 729 742 (Pubitemid 46100257)
42. M. Seitz, A. Shukla-Dave, A. Bjartell, K. Touijer, A. Sciarra, and P. Bastian Functional Magnetic Resonance Imaging in Prostate Cancer Eur Urol 55 2009 814 891 (Pubitemid 350045866)
43. A. Shukla-Dave, H. Hricak, N.M. Ishill, C.S. Moskowitz, M. Drobnjak, and V.E. Reuter Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer Radiology 250 2009 803 812
44. G.M. Villeirs, G.O. De Meerleer, P.J. De Visschere, V.H. Fonteyne, A.C. Verbaeys, and W. Oosterlinck Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: A single-institution experience of 356 patients Eur J Radiol 2009 [Epub ahead of print]
45. Y. Kubota, S. Kamei, M. Nakano, H. Ehara, T. Deguchi, and O. Tanaka The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer Int J Urol 15 2008 322 326 (Pubitemid 351490143)
46. S. Xu, J. Kruecker, B. Turkbey, N. Glossop, A.K. Singh, and P. Choyke Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies Comput Aided Surg 13 2008 255 264
47. A. Shukla-Dave, H. Hricak, S.C. Eberhardt, S. Olgac, M. Muruganandham, and P.T. Scardino Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings - initial observations Radiology 231 2004 717 724 (Pubitemid 38668088)
48. G.J. Kelloff, P. Choyke, and D.S. Coffey Challenges in clinical prostate cancer: role of imaging Am J Roentgenol 192 2009 1455 1470
49. M.R. Engelbrecht, G.J. Jager, R.J. Laheij, A.L. Verbeek, H.J. van Lier, and J.O. Barentsz Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis Eur Radiol 12 2002 2294 2302 (Pubitemid 36940327)
50. J.A. Smith Jr, P.T. Scardino, M.I. Resnick, A.D. Hernndez, S.C. Rose, and M.J. Egger Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial J Urol 157 1997 902 906 (Pubitemid 27066276)
51. F.G. Claus, H. Hricak, and R.R. Hattery Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy Radiographics 24 Suppl 1 2004 S167 S180 (Pubitemid 39457252)
52. S. White, H. Hricak, R. Forstner, J. Kurhanewicz, D.B. Vigneron, and C.J. Zaloudek Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images Radiology 195 1995 385 390 (Pubitemid 28128531)
53. L. Wang, M. Mullerad, H.N. Chen, S.C. Eberhardt, M.W. Kattan, and P.T. Scardino Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension Radiology 232 2004 133 139 (Pubitemid 38787828)
54. G.J. Jager, J.L. Severens, J.R. Thornbury, J.J. de la Rosette, S.H. Ruijs, and J.O. Barentsz Prostate cancer staging: should MR imaging be used? A decision analytic approach Radiology 215 2000 445 451 (Pubitemid 30237843)
55. V. Poulakis, U. Witzsch, V.R. de, V. Emmerlich, M. Meves, and H.M. Altmannsberger Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage J Urol 172 2004 1306 1310 (Pubitemid 39249703)
56. L. Wang, H. Hricak, M.W. Kattan, L.H. Schwartz, S.C. Eberhardt, and H.N. Chen Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer Am J Roentgenol 186 2006 743 748 (Pubitemid 46100258)
57. A.M. Hovels, R.A. Heesakkers, E.M. Adang, J.O. Barentsz, G.J. Jager, and J.L. Severens Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer Radiology 252 2009 729 736 (Pubitemid 46788742)
58. G. Ravizzini, B. Turkbey, K. Kurdziel, and P.L. Choyke New horizons in prostate cancer imaging Eur J Radiol 70 2009 212 226 (Pubitemid 46579693)
59. J. Barcelo, J.C. Vilanova, E. Riera, E. Balliu, I. Pelaez, and J. Marti Resonancia magntica de todo el cuerpo con tcnica de difusin (PET virtual) para el cribado de las metstasis seas Radiologia 49 2007 407 415 (Pubitemid 350131823)
60. R. Venkitaraman, G.J. Cook, D.P. Dearnaley, C.C. Parker, R.A. Huddart, and V. Khoo Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer? Clin Oncol (R Coll Radiol) 21 2009 39 42
61. S. Cirillo, M. Petracchini, L. Scotti, T. Gallo, A. Macera, and M.C. Bona Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging Eur Radiol 19 2009 761 769
62. D. Pucar, A. Shukla-Dave, H. Hricak, C.S. Moskowitz, K. Kuroiwa, and S. Olgac Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience Radiology 236 2005 545 553 (Pubitemid 41023438)
63. U.G. Mueller-Lisse, D.B. Vigneron, H. Hricak, M.G. Swanson, P.R. Carroll, and A. Bessette Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study Radiology 221 2001 380 390 (Pubitemid 33043420)
64. J. Kurhanewicz, D.B. Vigneron, H. Hricak, F. Parivar, S.J. Nelson, and K. Shinohara Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging Radiology 200 1996 489 496 (Pubitemid 26249904)
65. S.E. Donnelly, B.J. Donnelly, J.C. Saliken, E.L. Raber, and A.D. Vellet Prostate cancer: gadolinium-enhanced MR imaging at 3 weeks compared with needle biopsy at 6 months after cryoablation Radiology 232 2004 830 833 (Pubitemid 39100270)
66. A.P. Kirkham, M. Emberton, I.M. Hoh, R.O. Illing, A.A. Freeman, and C. Allen MR imaging of prostate after treatment with high-intensity focused ultrasound Radiology 246 2008 833 844
67. O. Akin, and H. Hricak Imaging of prostate cancer Radiol Clin North Am 45 2007 207 222 (Pubitemid 44854046)
68. A. Sciarra, V. Panebianco, S. Salciccia, M. Osimani, D. Lisi, and M. Ciccariello Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer Eur Urol 54 2008 589 600
69. T. Sella, L.H. Schwartz, P.W. Swindle, C.N. Onyebuchi, P.T. Scardino, and H.I. Scher Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging Radiology 231 2004 379 385 (Pubitemid 38552892)